183 related articles for article (PubMed ID: 37037826)
1. Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Bae M; Kim G; Lee TR; Ahn JM; Park H; Park SR; Song KB; Jun E; Oh D; Lee JW; Park YS; Song KW; Byeon JS; Kim BH; Sohn JH; Kim MH; Kim GM; Chie EK; Kang HC; Kong SY; Woo SM; Lee JE; Ryu JM; Lee J; Kim D; Ki CS; Cho EH; Choi JK
Nat Commun; 2023 Apr; 14(1):2017. PubMed ID: 37037826
[TBL] [Abstract][Full Text] [Related]
2. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
[TBL] [Abstract][Full Text] [Related]
3. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
4. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.
Koeppel F; Blanchard S; Jovelet C; Genin B; Marcaillou C; Martin E; Rouleau E; Solary E; Soria JC; André F; Lacroix L
PLoS One; 2017; 12(11):e0188174. PubMed ID: 29161279
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
Moldovan N; van der Pol Y; van den Ende T; Boers D; Verkuijlen S; Creemers A; Ramaker J; Vu T; Bootsma S; Lenos KJ; Vermeulen L; Fransen MF; Pegtel M; Bahce I; van Laarhoven H; Mouliere F
Cell Rep Med; 2024 Jan; 5(1):101349. PubMed ID: 38128532
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
[TBL] [Abstract][Full Text] [Related]
8. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
Gao Q; Lin YP; Li BS; Wang GQ; Dong LQ; Shen BY; Lou WH; Wu WC; Ge D; Zhu QL; Xu Y; Xu JM; Chang WJ; Lan P; Zhou PH; He MJ; Qiao GB; Chuai SK; Zang RY; Shi TY; Tan LJ; Yin J; Zeng Q; Su XF; Wang ZD; Zhao XQ; Nian WQ; Zhang S; Zhou J; Cai SL; Zhang ZH; Fan J
Ann Oncol; 2023 May; 34(5):486-495. PubMed ID: 36849097
[TBL] [Abstract][Full Text] [Related]
9. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
10. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
[TBL] [Abstract][Full Text] [Related]
11. Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer.
Wang S; Meng F; Li M; Bao H; Chen X; Zhu M; Liu R; Xu X; Yang S; Wu X; Shao Y; Xu L; Yin R
Am J Respir Crit Care Med; 2023 May; 207(9):1203-1213. PubMed ID: 36346614
[No Abstract] [Full Text] [Related]
12. Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis.
Zhou X; Cheng Z; Dong M; Liu Q; Yang W; Liu M; Tian J; Cheng W
Nat Commun; 2022 Dec; 13(1):7694. PubMed ID: 36509772
[TBL] [Abstract][Full Text] [Related]
13. Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics.
Wang F; Li X; Li M; Liu W; Lu L; Li Y; Chen X; Yang S; Liu T; Cheng W; Weng L; Wang H; Lu D; Yao Q; Wang Y; Wu J; Wittkop T; Faham M; Zhou H; Hu H; Jin H; Hu Z; Ma D; Cheng X
Clin Chem Lab Med; 2024 Jan; 62(1):168-177. PubMed ID: 37678194
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
15. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
Bos MK; Angus L; Nasserinejad K; Jager A; Jansen MPHM; Martens JWM; Sleijfer S
Cancer Treat Rev; 2020 Feb; 83():101951. PubMed ID: 31874446
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
18. High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.
Kujala J; Hartikainen JM; Tengström M; Sironen R; Kosma VM; Mannermaa A
Cancer Med; 2020 Aug; 9(16):5922-5931. PubMed ID: 32602248
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer.
Gou Q; Zhang CZ; Sun ZH; Wu LG; Chen Y; Mo ZQ; Mai QC; He J; Zhou ZX; Shi F; Cui W; Zou W; Lv L; Zhuang WH; Xu RD; Li WK; Zhang J; Du HW; Xiang JX; Wang HZ; Hou T; Li ST; Li Y; Chen XM; Zhou ZJ
ESMO Open; 2021 Dec; 6(6):100275. PubMed ID: 34653800
[TBL] [Abstract][Full Text] [Related]
20. Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization.
Renaud G; Nørgaard M; Lindberg J; Grönberg H; De Laere B; Jensen JB; Borre M; Andersen CL; Sørensen KD; Maretty L; Besenbacher S
Elife; 2022 Jul; 11():. PubMed ID: 35894300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]